MX2016009751A - Agente mejorador del efecto de la rehabilitacion despues de una lesion nerviosa que comprende un derivado de eter de alquilo o una sal del mismo. - Google Patents
Agente mejorador del efecto de la rehabilitacion despues de una lesion nerviosa que comprende un derivado de eter de alquilo o una sal del mismo.Info
- Publication number
- MX2016009751A MX2016009751A MX2016009751A MX2016009751A MX2016009751A MX 2016009751 A MX2016009751 A MX 2016009751A MX 2016009751 A MX2016009751 A MX 2016009751A MX 2016009751 A MX2016009751 A MX 2016009751A MX 2016009751 A MX2016009751 A MX 2016009751A
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- alkyl ether
- enhancing agent
- nerve injury
- ether derivative
- Prior art date
Links
- 208000028389 Nerve injury Diseases 0.000 title abstract 2
- 150000005215 alkyl ethers Chemical class 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 230000008764 nerve damage Effects 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporciona una composición medicinal caracterizada porque comprende un derivado de éter de alquilo representado por la fórmula general [1] (ver Fórmula) en donde R1 y R2 son los mismos o diferentes y representan un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo C1-6 opcionalmente sustituido, un grupo arilo opcionalmente sustituido, etc.; R3 representa un grupo hidroxilo opcionalmente protegido; etc., y m y n son los mismos o diferentes, y representan un número entero desde 1 hasta 6] o una sal del mismo. La composición medicinal de acuerdo con la presente invención es útil como un agente mejorador del efecto de la rehabilitación después de una lesión nerviosa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014017587 | 2014-01-31 | ||
| PCT/JP2015/052617 WO2015115582A1 (ja) | 2014-01-31 | 2015-01-30 | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016009751A true MX2016009751A (es) | 2016-11-08 |
Family
ID=53757150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016009751A MX2016009751A (es) | 2014-01-31 | 2015-01-30 | Agente mejorador del efecto de la rehabilitacion despues de una lesion nerviosa que comprende un derivado de eter de alquilo o una sal del mismo. |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US10039744B2 (es) |
| EP (1) | EP3100725B1 (es) |
| JP (3) | JP5837726B1 (es) |
| KR (1) | KR102346219B1 (es) |
| CN (1) | CN106061478B (es) |
| AU (1) | AU2015211753B2 (es) |
| BR (1) | BR112016017747A2 (es) |
| CA (1) | CA2938184C (es) |
| CY (1) | CY1123154T1 (es) |
| DK (1) | DK3100725T3 (es) |
| ES (1) | ES2792950T3 (es) |
| HR (1) | HRP20200796T1 (es) |
| HU (1) | HUE050400T2 (es) |
| IL (1) | IL246925B (es) |
| LT (1) | LT3100725T (es) |
| MX (1) | MX2016009751A (es) |
| MY (1) | MY179290A (es) |
| PH (1) | PH12016501507A1 (es) |
| PL (1) | PL3100725T3 (es) |
| PT (1) | PT3100725T (es) |
| RS (1) | RS60462B1 (es) |
| RU (1) | RU2680247C2 (es) |
| SG (2) | SG11201606173TA (es) |
| SI (1) | SI3100725T1 (es) |
| SM (1) | SMT202000395T1 (es) |
| WO (1) | WO2015115582A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3100725T (lt) * | 2014-01-31 | 2020-08-10 | Fujifilm Toyama Chemical Co., Ltd. | Reabilitacijos poveikį po nervo pažeidimo sustiprinanti priemonė, apimanti alkileterio darinį arba jo druską |
| DK3395342T3 (da) * | 2015-12-25 | 2020-10-12 | Fujifilm Toyama Chemical Co Ltd | Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf |
| WO2018124282A1 (ja) * | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 医薬組成物およびその製造方法 |
| CN110167551B (zh) * | 2016-12-28 | 2022-06-14 | 富士胶片富山化学株式会社 | 医药组合物 |
| EP3563847B1 (en) * | 2016-12-28 | 2023-09-20 | FUJIFILM Toyama Chemical Co., Ltd. | Pharmaceutical composition |
| EP3563843A4 (en) * | 2016-12-28 | 2019-12-11 | FUJIFILM Toyama Chemical Co., Ltd. | TOPICAL COMPOSITION |
| EP3636262A4 (en) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | AGENT FOR PREVENTING OR TREATING ALZHEIMER-LIKE DEMENTIA |
| SG11201911519UA (en) | 2017-06-02 | 2020-01-30 | Fujifilm Toyama Chemical Co Ltd | AGENT FOR REDUCING AMOUNT OF AMYLOID ß PROTEIN |
| WO2018221730A1 (ja) * | 2017-06-02 | 2018-12-06 | 富山化学工業株式会社 | 脊髄小脳変性症予防または治療剤 |
| RU2739199C1 (ru) * | 2017-06-02 | 2020-12-21 | ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. | Лекарственное средство для предотврашения или лечения таупатии |
| CN116473962A (zh) | 2017-06-02 | 2023-07-25 | 富士胶片富山化学株式会社 | 脑萎缩预防或治疗剂 |
| JP7227914B2 (ja) | 2017-10-30 | 2023-02-22 | 富士フイルム富山化学株式会社 | エモパミル結合タンパク質結合剤およびその利用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE43676E1 (en) | 2001-10-19 | 2012-09-18 | Toyama Chemical Co., Ltd. | Alkyl ether derivatives or salts thereof |
| US7753054B2 (en) | 2001-11-29 | 2010-07-13 | Japan Science And Technology Agency | Method of constructing spinal injury model monkey and utilization thereof |
| TR201816386T4 (tr) * | 2002-06-14 | 2018-11-21 | Toyama Chemical Co Ltd | Beyin fonksiyonunu arttırmak için tıbbi bileşim. |
| US20060205709A1 (en) * | 2003-04-17 | 2006-09-14 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| CA2799659C (en) | 2005-03-28 | 2014-12-02 | Toyama Chemical Co., Ltd. | Process for production of 1-(3-(2-(1-benzothiophen-5-yl) ethoxy)propyl) azetidin-3-ol or salts thereof |
| RU2397169C2 (ru) * | 2005-03-28 | 2010-08-20 | Тояма Кемикал Ко., Лтд. | Способ получения 1-(3-(2-(1-бензотиофен-5-ил)этокси) пропил)азетидин-3-ола или его солей |
| US8119625B2 (en) * | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| ZA200808728B (en) * | 2006-04-26 | 2010-01-27 | Toyama Chemical Co Ltd | Neurogenesis inducer or neuropathy Therapeutic agent comprising alkyl ether derivative or salt thereof |
| LT3100725T (lt) * | 2014-01-31 | 2020-08-10 | Fujifilm Toyama Chemical Co., Ltd. | Reabilitacijos poveikį po nervo pažeidimo sustiprinanti priemonė, apimanti alkileterio darinį arba jo druską |
-
2015
- 2015-01-30 LT LTEP15743367.3T patent/LT3100725T/lt unknown
- 2015-01-30 SG SG11201606173TA patent/SG11201606173TA/en unknown
- 2015-01-30 WO PCT/JP2015/052617 patent/WO2015115582A1/ja not_active Ceased
- 2015-01-30 SG SG10201907035TA patent/SG10201907035TA/en unknown
- 2015-01-30 CA CA2938184A patent/CA2938184C/en active Active
- 2015-01-30 DK DK15743367.3T patent/DK3100725T3/da active
- 2015-01-30 US US15/115,416 patent/US10039744B2/en active Active
- 2015-01-30 HR HRP20200796TT patent/HRP20200796T1/hr unknown
- 2015-01-30 CN CN201580011450.3A patent/CN106061478B/zh active Active
- 2015-01-30 RU RU2016135236A patent/RU2680247C2/ru active
- 2015-01-30 HU HUE15743367A patent/HUE050400T2/hu unknown
- 2015-01-30 MY MYPI2016702668A patent/MY179290A/en unknown
- 2015-01-30 PL PL15743367T patent/PL3100725T3/pl unknown
- 2015-01-30 AU AU2015211753A patent/AU2015211753B2/en active Active
- 2015-01-30 BR BR112016017747A patent/BR112016017747A2/pt not_active Application Discontinuation
- 2015-01-30 KR KR1020167023717A patent/KR102346219B1/ko active Active
- 2015-01-30 PT PT157433673T patent/PT3100725T/pt unknown
- 2015-01-30 MX MX2016009751A patent/MX2016009751A/es active IP Right Grant
- 2015-01-30 RS RS20200754A patent/RS60462B1/sr unknown
- 2015-01-30 EP EP15743367.3A patent/EP3100725B1/en active Active
- 2015-01-30 SI SI201531278T patent/SI3100725T1/sl unknown
- 2015-01-30 JP JP2015539315A patent/JP5837726B1/ja active Active
- 2015-01-30 ES ES15743367T patent/ES2792950T3/es active Active
- 2015-01-30 SM SM20200395T patent/SMT202000395T1/it unknown
- 2015-11-04 JP JP2015216722A patent/JP6642914B2/ja active Active
-
2016
- 2016-07-25 IL IL24692516A patent/IL246925B/en active IP Right Grant
- 2016-07-29 PH PH12016501507A patent/PH12016501507A1/en unknown
-
2018
- 2018-06-12 US US16/005,774 patent/US10471044B2/en active Active
-
2019
- 2019-12-26 JP JP2019236541A patent/JP6825074B2/ja active Active
-
2020
- 2020-07-23 CY CY20201100673T patent/CY1123154T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501507A1 (en) | Post nerve injury rehabilitation effect-enhancing agent comprising alkyl ether derivative or salt thereof | |
| JOP20200225A1 (ar) | مشتق كوينولين عالي النقاء وطريقة لإنتاجه | |
| UY40612A (es) | Piridinas sustituidas con heteroarilo y métodos de uso | |
| GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
| PH12014502866A1 (en) | Fungicidal heterocyclic carboxamides | |
| JO3807B1 (ar) | مشتقات حمض هيدروكسي جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
| TN2015000245A1 (en) | Heterocyclic compound | |
| PH12022552034A1 (en) | Pyridone derivative having tetrahydropyranyl methyl group | |
| MX376283B (es) | Compuestos de imidazopiridazina. | |
| MX2015001099A (es) | Nuevos derivados biciclicos de piridina. | |
| DOP2020000118A (es) | Proceso para la preparación de derivados de quinolina | |
| EA201792425A1 (ru) | Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз | |
| CL2017000103A1 (es) | Derivados de bis(aril)catecol como herbicidas | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| MY170262A (en) | Dicarboxylic acid compound | |
| NZ703217A (en) | Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same | |
| MX2016005993A (es) | Anfifilos biscationicos y triscationicos como agentes antimicrobianos. | |
| MX2019004294A (es) | Derivados de fenilamina 4-sustituidos y su uso para proteger cultivos al combatir microorganismos fitopatogenicos indeseados. | |
| JO3264B1 (ar) | مركبات ازيتيدينيل أوكسي فينيل بيروليدين | |
| MX386501B (es) | Compuestos terapeuticos y sus metodos de uso | |
| UA111950C2 (uk) | Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну | |
| MX2018016339A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
| MX2015010790A (es) | Derivados de anilina sustituidos con n-heteroarilo como antivirales de vhc. | |
| MX2017001320A (es) | Amidas del acido arilcarboxilico biciclicas y su uso como herbicidas. | |
| MX377963B (es) | Composición acuosa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |